This work is licensed under a Creative Commons Attribution 4.0 International License.
General Information
DRACP ID DRACP04524
Peptide Name
Sequence CLLFVY
Sequence Length 6
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C38H56N6O8S
Absent amino acids ADEGHIKMNPQRSTW
Common amino acids L
Mass 84633
Pl 5.91
Basic residues 0
Acidic residues 0
Hydrophobic residues 4
Net charge 0
Boman Index 1800
Hydrophobicity 263.33
Aliphatic Index 178.33
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 1490
Absorbance 280nm 298
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23796364
Title A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells
Doi Not available
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 20455
This work is licensed under a Creative Commons Attribution 4.0 International License.